SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-147583
Filing Date
2024-05-28
Accepted
2024-05-28 07:09:32
Documents
15
Period of Report
2024-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d717537d8k.htm   iXBRL 8-K 27712
2 EX-99.1 d717537dex991.htm EX-99.1 12474
6 GRAPHIC g717537g0523104156625.jpg GRAPHIC 3223
  Complete submission text file 0001193125-24-147583.txt   169078

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agio-20240524.xsd EX-101.SCH 2833
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20240524_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20240524_pre.xml EX-101.PRE 10801
18 EXTRACTED XBRL INSTANCE DOCUMENT d717537d8k_htm.xml XML 3503
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 24986255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)